Remdesivir in COVID-19 Lahore General Hospital

Clinical trial NCT04560231 · UNKNOWN

Trial details

NCT number: NCT04560231
Sponsor: Lahore General Hospital
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

SARS-CoV Infection

Start date: 2020-06-01
Primary completion: 2020-11-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.